IVF/ART
SATURDAY, NOVEMBER 26

08:30-10:00 OVARIAN STIMULATION HALL A
Capsule What can be done to improve ovarian stimulation?
Chairpersons Rene FrydmanFrance
Zion Ben Rafael, Israel
08:30-09:00

08:30
08:40
08:50

Debate: Ovarian Stimulation, Mild or Wild or in between
Mild and Safe? Frank Broekmans, Netherlands
Personalized: Ernesto Bosch, Spain
Discussion
09:00-09:20 What is the optimal number of oocytes we should aim for with ovarian stimulation?
Bart Fauser, Netherlands
 09:20-09:40 The type of gonadotrophin for stimulation: Does it matter?
Ernesto Bosch, Spain
09:40-10:00 Stimulation strategies for DOR
Carlo Alviggi, Italy

 

10:00-10:20 Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 HITECH IVF HALL A
Capsule

These procedures need more proof before using it routinely in the clinic.

Chairpersons Rene Frydman, France
Catherine Racowsky, France
10:20-10:45 IVM at time of OTC (Ovarian tissue cryopreservation)
Claus Yding Andersen, Denmark
10:45-11:05 Nuclear transplantation for patients with recurrent IVF failure
Jacques Cohen, USA
11:05-11:30 Rejuvenating the ovary by stem cell therapy
Nuria Pellicier, Spain
11:30-11:50 Can mitochondrial transfer rejuvenate older oocytes?
TBA

 

11:50-12:00 Break

 

12:00-13:30 FERTILITY PRESERVATION HALL A
Capsule Fertility preservation use is growing and so are the doubts surrounding these procedures
 Chairpersons Claus Yding Andersen, Denmark
Norbert Gleicher, USA
12:00-12:35

12:00
12:10
12:20

Debate: Should we move from fertility preservation to oocytes donation for young women with cancer? When?
Preservation of fertility: Catherine Racowsky, France
Prefer egg Donation: Edgardo Somigliana, Italy
Discussion
12:20-12:35 Fertility preservation in oncological patients
Jacques Donnez, Belgium
12:55-13:30

12:55
13:05
13:15

Debate: Asherman syndrome surgery or stem cells?
Surgery: You don’t need stem cells; you need good surgeons: Miriam Hanstede, Netherlands 
Stem cells: treat endometrial atrophy through tissue engineering: Nuria Pellicier, Spain
Discussion

 

13:30-14:30  Lunch break,  moderated e-posters and visit the exhibition Exhibition Area

 

14:30-16:30

ENDOMETRIOSIS AND INFERTILITY

HALL A
Capsule The challenge is to select the best treatment
Chairpersons Norbert Gleicher, USA
Jacques Donnez, Belgium
14:30-14:50

Endometriosis: Does it impact oocyte quality
Catherine Racowsky, France

14:50-15:10

Endometriosis – surgery vs conventional ART for infertility
Edgardo Somigliana, Italy

15:10-15:45

15:10
15:20
15:30

Debate: Long term risk of cancer in Endometrioma: Immediate surgery, delayed surgery or never surgery?
Delayed surgery:  Jacques Donnez, Belgium
Immediate surgery: Hans NijmanNetherlands
Discussion

 15:45-:16:05

Fertility preservation in endometriosis: When should it be offered
Edgardo Somigliana, Italy

16:05-16:30

Oral GnRH Antagonist for treatment of endometriosis
Nicholas Leyland, Canada

 

16:30-16:50  Coffee break,  e-poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 ORAL PRESENTATIONS HALL A
Skip to content